Abstract

Dear Editor,
We read with interest the article by Keser et al. 1 published entitled Keser BN, Kirman UN, Kocaaslan C, Aydin E. The association between vascular access type and depressive symptoms in geriatric hemodialysis population. Vascular 2020; 28(4): 390–395. doi:10.1177/1708538120905725
We have some doubts in this manuscript. In the study, there are no clear data about whether patients with a score of 5 and above on the depression scale received medical depression treatment. If depression symptoms do not improve despite receiving treatment, could hemodialysis have an important role in the elimination mechanisms of the drugs used?
In the study, it was stated that hypertension (HT) is a predictor of the development of depressive symptoms. What is this relationship based on? Do HT patients receive optimal antihypertensive therapy?
Is there any difference in the development of depression symptoms between the central venous catheters used? (femoral or jugular vein)
We congratulate Keser et al. for their actual and valuable study about depression in hemodialysis patients. We would like to hear the authors’ opinion on this matter.
Footnotes
Declaration of conflicting interests
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Funding
The author(s) received no financial support for the research, authorship, and/or publication of this article.
